Modes of presentation of chemical neoantigens to the immune system

Toxicology

Volumn 181-182, Issue , 2002, Pages 49-54

  Pichler, Werner J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Drug allergy; Hypersensitivity; Immunotoxicology; Neoantigens

Indexed keywords

ANTIGEN; CARBAMAZEPINE; CELECOXIB; CEPHALOSPORIN DERIVATIVE; HAPTEN; HEPARIN DERIVATIVE; IMMUNOGLOBULIN; LIDOCAINE; MEPIVACAINE; PENICILLIN DERIVATIVE; PYRAZOLONE DERIVATIVE; SULFAMETHOXAZOLE; SULFONAMIDE; T LYMPHOCYTE RECEPTOR;

ALLERGY TEST; ANAPHYLAXIS; ARTICLE; DRUG HYPERSENSITIVITY; HEMOLYTIC ANEMIA; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; SIDE EFFECT; T LYMPHOCYTE; THROMBOCYTOPENIA;

ANIMALS; ANTIGENS; DRUG HYPERSENSITIVITY; HAPTENS; HUMANS; PHARMACEUTICAL PREPARATIONS; PREDICTIVE VALUE OF TESTS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 0037184719     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00254-8     Document Type: Article

References (18)

1. Britschgi M., Steiner U., Schmid S., Senti G., Bircher A., Burkhart C., Yawalkar N., Pichler W.J. T cell involvement in drug-induced acute generalized exanthematous pustulosis. J. Clin. Invest. 107:2001;423-428.
2. Li H., Llera A., Malchiodi E.L., Mariuzza R.A. The structural basis of T cell activation by superantigens. Ann. Rev. Immunol. 17:1999;435-466.
3. Naisbitt D.J., Gordon S.F., Pirmohamed M., Park B.K. Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug Saf. 23:(6):2000;483-507.
4. Nassif A., Bensussan A., Dorothée G., Mami-Chouaib F., Bachot N., Bagot M., Bumsell L., Roujeau J.C. Drug-specific cytotoxic T lymphocytes in the skin lesions of a patient with toxic epidermal necrolysis. J. Invest. Dermatol. 118:2002;728-733.
5. Park B.K., Pirmohamed M., Kitteringham N.R. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem. Res. Toxicol. 11:1998;969-988.
6. Pichler W.J. Drug allergy: relationship between immunogenicity and clinical symptoms. Allergy. 54:(Suppl 58):1999;5-7.
7. Pichler W.J. Predictive drug allergy testing, an alternative viewpoint. Toxicology. 158:2001;31-41.
8. Pichler W.J., Schnyder B., Zanni M., Hari Y., von Greyerz S. Role of T cells in drug allergies. Allergy. 53:1998;225-232.
9. Schnyder B., Mauri-Hellweg D., Zanni M., et al. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human T cell clones. J. Clin. Invest. 100:1997;136-141.
10. Schnyder B., Frutig K., Mauri-Hellweg D., et al. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction. Clin. Exp. Allergy. 28:1998;1412-1417.
11. Schnyder B., Burkhart Ch., Schnyder-Frutig K., von Greyerz S., Naisbitt D., Pirmohamed M., Park K., Pichler W.J. Recognition of sulfamethoxazole and its reactive metabolites by drug specific T cells from allergic individuals. J. Immunol. 164:2000;6647-6654.
12. von Greyerz S., Burkhart C., Pichler W.J. Molecular basis of drug recognition by specific T cell receptors. Int. Arch. Allergy Immunol. 119:1999;173-180.
13. + T cell clones. Int. Immunol. 7:2001;877-885.
14. Yawalkar N., Egli F., Hari Y., et al. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin. Exp. Allergy. 30:2000;847-855.
15. Zanni M.P., Mauri-Hellweg D., Brander C., et al. Characterization of lidocaine-specific T cells. J. Immunol. 158:1997;1139-1148.
16. Zanni M.P., von Greyerz S., Schnyder B., Brander K.A., Frutig K., Hari Y., Valitutti S., Pichler W.J. HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human αβ T lymphocytes. J. Clin. Invest. 102:1998;1591-1598.
17. Zanni M.P., von Greyerz S., Schnyder B., Wendland T., Pichler W.J. HLA-unrestricted presentation of lidocaine by HLA-DR molecules to specific αβ+ T cell clones. Immunol. Int. 10:1998;507-515.
18. Zanni M.P., von Greyerz S., Hari Y., Schnyder B., Pichler W.J. Recognition of local anaesthetics by αβ+ T cells. J. Invest. Dermatol. 112:1999;197-204.